As of June 27, 2026, Odyssey Therapeutics, Inc. (ODTX) has a DilutionWatch DilutionScore of 51/100, rated HIGH dilution risk. Odyssey Therapeutics, Inc. has a market capitalization of $802.43M, 47.17M shares outstanding.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ODTX.
💹 Market Data
Market Cap$802.43M
Shares Outstanding47.17M
Float11.59M
Cash$187.00M
Debt$34.38M
Short InterestN/A
🏛 Institutional Holdings
38.4% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest1.34M
Days to Cover4.8
% of Float11.6%
FINRA data as of Jun 15, 2026
📁 Recent SEC Activity
4
INSIDER TRANSACTION
May 13, 2026
3
FORM3
May 12, 2026
4
INSIDER TRANSACTION
May 12, 2026
4
INSIDER TRANSACTION
May 11, 2026
4
INSIDER TRANSACTION
May 11, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
Track ODTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ODTX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for ODTX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.